Irish Pharma in E40 Million U.S. Placement

Azur Pharma, the biotech firm headed by former Elan executive, Seamus Mulligan, said it has successfully completed a private placement of equity securities worth E40 million. Azur Pharma was founded in March of this year with the aim of, through selective acquisitions, to build a portfolio of established pharmaceutical brands and enhance their value through focused sales and marketing activities and the application of drug delivery technologies.

()a href="http://www.businessworld.ie/livenews.htm?a=1187965;s=rollingnews.htm" target="_blank">Business World